Theriva Biologics (TOVX) Receivables - Other (2017 - 2026)
Theriva Biologics (TOVX) reported Receivables - Other of $1.68 million for Q2 2026, down 2.4% from $1.72 million a year earlier and down 0.9% from the prior quarter.
Powered by 
Analysis
Theriva Biologics (TOVX) Receivables - Other (2017 - 2026) Analysis & Trends
At the end of FY2025, Theriva Biologics posted Receivables - Other of $3.35 million, up 3.8% from FY2024.
- Receivables - Other has a five-year compound annual growth rate of 48.2% (FY2020 to FY2025).
- By year, Receivables - Other came in at $3.23 million in FY2024 (+78.1%), $1.81 million in FY2023 and $87,000 in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Receivables - Other since Q1 2025.
- Year over year, Receivables - Other gained in four of the last eight quarters, with growth averaging 12.3%.
- The high point for year-over-year Receivables - Other in five years was Q3 2023 (growth of 553.7%); the low point was Q1 2023 (a decline of 96.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.7 million (Q1 2026), $3.35 million (Q4 2025) and $1.72 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Theriva Biologics | 10.56 Mn | 10.56 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.68 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 3.35 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 1.72 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 3.23 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 1.76 Mn |
| Mar 31, 2024 | 1.77 Mn |
| Dec 31, 2023 | 1.81 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 144,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 87,000.00 |
| Sep 30, 2022 | 214,000.00 |
| Jun 30, 2022 | 278,000.00 |
| Mar 31, 2022 | 127,000.00 |
| Dec 31, 2020 | 469,000.00 |
| Dec 31, 2019 | 3,000.00 |
API Access
Theriva Biologics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=TOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();